Annual Drug Patent Expiration for QUILLICHEW+ER
Quillichew Er is a drug marketed by Nextwave Pharms and is included in one NDA. It is available from a single supplier. There are nine patents protecting this drug.
Price trends for QUILLICHEW ER drugs.
Drug patent litigation for QUILLICHEW ER.
This drug has thirty-four patent family members in fourteen countries.
The generic ingredient in QUILLICHEW ER is methylphenidate hydrochloride. One registered supplier for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for Nextwave Pharms drug QUILLICHEW ER